Dr. Tang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Summary
- I am a Board-certified heart failure/transplant cardiologist and a clinician-scientist with a translational research focuses on understanding the cellular and molecular mechanisms that contribute to disease progression in heart failure and cardiomyopathy.
Education & Training
- Cleveland Clinic FoundationFellowship, Advanced Heart Failure and Transplant Cardiology, 2003 - 2004
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2000 - 2003
- Stanford Health CarePost-Doctoral Fellowship, 1999 - 2000
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1997 - 1999
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1996 - 1997
- Harvard Medical SchoolClass of 1996
- Jesus College, University of CambridgePart II Tripos, Molecular Medicine, 1991 - 1992
- Jesus College, University of CambridgePart II Tripos, Molecular Medicine, 1991 - 1992
- Brown UniversityB.S., Neural Sciences, 1992
Certifications & Licensure
- CA State Medical License 1997 - 2026
- OH State Medical License 2000 - 2025
- HI State Medical License 1998 - 1998
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Sones/Favoloro Award Cleveland Clinic, 2019
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Distinguished Faculty Award for Excellence in Research Mentorship Cleveland Clinic, 2009
- Join now to see all
Clinical Trials
- Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) Start of enrollment: 2013 Apr 01
- Respicardia, Inc. Pivotal Trial of the remedē System Start of enrollment: 2013 Mar 01
- Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsNegative Predictive Value and Prognostic Associations of Rb-82 PET/CT with Myocardial Blood Flow in CAV.Bryan Q Abadie, Nicholas Chan, Zarina Sharalaya, Pavan Bhat, Serge Harb
JACC. Heart Failure. 2023-05-01 - Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction.Chayakrit Krittanawong, Mario Rodriguez, Matthew Lui, Arunima Misra, W H Wilson Tang
The American Journal of Medicine. 2023-05-01 - 5 citationsSignificance of Pulmonary Hypertension in Cardiac Amyloidosis.Joshua Longinow, Jonathan Buggey, Miriam Jacob, Pieter Martens, Mazen Hanna
The American Journal of Cardiology. 2023-04-01
Journal Articles
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarctionDo R, Stitziel NO, Won HH, Jørgensen AB, Duga S, Angelica Merlini P, Kiezun A, Farrall M, Goel A, Zuk O, Guella I, Asselta R, Lange LA, Peloso GM, Auer PL; NHLBI Exome..., Nature, 1/1/2015
- Gut Microbiota-Dependent Trimethylamine N-oxide (TMAO) Pathway Contributes to both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney DiseaseTang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, & Hazen SL, Circ Res, 1/1/2015
- Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated with Right Ventricular Dysfunction and Nitrative Stress in Heart FailureKennedy DJ, Shrestha K, Sheehy B, Li XS, Guggilam A, Wu Y, Finucan M, Gabi A, Medert CM, Westfall K, Borowski A, Fedorova O, Bagrov AY, Tang WH, Circ Heart Fail, 1/1/2015
- Join now to see all
Press Mentions
- Blood Clotting Risk Doubles with Erythritol Consumption: Insights from Pilot StudyAugust 13th, 2024
- Sweetener Sold in Tesco and Asda and Found in Low-Calorie Snacks ‘May Increase Risk of Heart Attack and Stroke’August 9th, 2024
- Erythritol, a Calorie-Free Sweetener, May Be Linked to Blood Clots and Heart Disease Risk, Study FindsAugust 9th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Heart Failure Society of AmericaFellow
- International Society of Heart and Lung TransplantationMember
- American Society of Clinical InvestigationMember
- Association of American PhysiciansMember
Other Languages
- Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: